Cited by 69Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsMicroRNA in disease regulation

Early diagnosis of Alzheimer's disease from elevated olfactory mucosal miR-206 level.

Open access
Moon, Jangsup, Lee, Soon-Tae, Kong, Il Gyu, Byun, Jung-Ick, Sunwoo, Jun-Sang, Shin, Jung-Won, Shim, Ji-Young, Park, Ji-Hyun +7 more·2016·Scientific Reports

Abstract

MicroRNA-206, which suppresses the expression of brain-derived neurotrophic factor, is known to be elevated in the brains of Alzheimer's disease (AD) patients. We performed intranasal biopsy of the olfactory epithelia of early dementia patients (n = 24) and cognitively healthy controls (n = 9). Patients with significant depression (n = 8) were analyzed separately, as their cognitive impairments were thought to be caused by their depression. Real-time PCR was performed on the biopsied tissues. The relative microRNA-206 level exhibited a 7.8-fold increase (P = 0.004) in the mild cognitive impairment group (CDR 0.5; n = 13) and a 41.5-fold increase (P < 0.001) in the CDR 1 group (n = 11). However, this level was not increased in the depression group, even in those with cognitive decline. Using the optimal cutoff value, the sensitivity/specificity for diagnosing CDR 0.5 and CDR 1 dementia were 87.5%/94.1% and 90.9%/93.3%, respectively. In ROC analysis, the AUCs were 0.942 and 0.976 in the CDR 0.5 and CDR 1 groups, respectively. The olfactory mucosal microRNA-206 level and cognitive assessment scores were significantly correlated in the non-depressed subjects with cognitive impairment. In conclusion, the olfactory mucosal microRNA-206 level can be easily measured, and it can be utilized as an excellent biomarker for the diagnosis of early AD, including mild cognitive impairment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep20364

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Moon, J., Lee, S.-T., Kong, I. G., Byun, J.-I., Sunwoo, J.-S., Shin, J.-W., Shim, J.-Y., Park, J.-H., Jeon, D., Jung, K.-H., Jung, K.-Y., Kim, D.-Y., Lee, S. K., Kim, M., & Chu, K.
Affiliations
  • Seoul National University (KR)
  • Hallym University Sacred Heart Hospital (KR)
  • CHA University (KR)
Corresponding author
  • Kim, Manho
  • Chu, Kon
Venue
Scientific Reports
Published
2016-02-04
Volume
6
Issue
1
Pages
20364-20364
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2418165897
Cited by
69
References
64
Citations by year
2026: 4 · 2025: 5 · 2024: 8 · 2023: 2 · 2022: 8 · 2021: 6 · 2020: 7 · 2019: 9 · 2018: 8 · 2017: 9 · 2016: 2 · 2014: 1
FWCI
8.29
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Keywords
Alzheimer's disease, miR-206, olfactory epithelium, early diagnosis, mild cognitive impairment, dementia, biomarkers, brain-derived neurotrophic factor, depression, cognitive impairment
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Cognition Disorders, Female, Humans, Male, Middle Aged, Olfactory Mucosa, ROC Curve, Biomarkers, Case-Control Studies, Area Under Curve, MicroRNAs, Early Diagnosis, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review